This application proposes to create and assess a new mode of active targeting for anticancer agents to solid tumors that develop an acidic extracellular environment. The current paradigm of active tumor targeting technology in chemotherapy is based on active internalization of drug carriers into cells by binding between a tumor specific antigen and its monoclonal antibody (mAb) or between a ligand and its corresponding receptor. In an attempt to shift this paradigm, an intelligent polymeric micelle system will be devised. The micelle will hide a particular moiety during circulation, which has the strong capability to translocate the micelle into cells, and expose the moiety in the tumor extracellular environment to facilitate the internalization process. Thus, micelle technology turns a non-specific cell internalizing vector into a tumor specific tool. For this purpose, the slightly acidic tumor extracellular pH (pHe: pH 6.6-7.0) has been selected as a triggering signal for exposure of the moiety because this acidity is natural in most solid tumors and is confined to extracellular space. This new system will broaden the range of solid tumors that can be treated using targeted chemotherapy and it is expected to replace cumbersome and expensive mAb-based targeting technology. The goal of this application is to design and construct a super pH-sensitive surface on a micelle core structure to provide exposure mechanisms for an internalizing agent. When this technology is successful, the micelle system will be capable of targeting anticancer drugs to most solid tumors that have pHe values below 7.0. This triggering pH was found to be reasonable, judging from our feasibility results obtained from two different micelle systems. In this application, a model cell penetrating peptide (CPP) TAT is utilized, which does not require particular antigens or receptors for cellular localization.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA122356-05
Application #
7893033
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Fu, Yali
Project Start
2006-08-22
Project End
2011-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
5
Fiscal Year
2010
Total Cost
$257,668
Indirect Cost
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Stirland, Darren L; Matsumoto, Yu; Toh, Kazuko et al. (2016) Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors. J Control Release 227:38-44
Stirland, Darren L; Nichols, Joseph W; Jarboe, Elke et al. (2015) Uterine perfusion model for analyzing barriers to transport in fibroids. J Control Release 214:85-93
Miura, Seiji; Suzuki, Hidenori; Bae, You Han (2014) A Multilayered Cell Culture Model for Transport Study in Solid Tumors: Evaluation of Tissue Penetration of Polyethyleneimine Based Cationic Micelles. Nano Today 9:695-704
Nichols, Joseph W; Bae, You Han (2014) EPR: Evidence and fallacy. J Control Release 190:451-64
Tian, Li; Kang, Han Chang; Bae, You Han (2013) Endosomolytic reducible polymeric electrolytes for cytosolic protein delivery. Biomacromolecules 14:2570-81
Nichols, Joseph W; Bae, You Han (2012) Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today 7:606-618
Denison, Tracy A; Bae, You Han (2012) Tumor heterogeneity and its implication for drug delivery. J Control Release 164:187-91
Tian, Li; Bae, You Han (2012) Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerfaces 99:116-26
Bae, You Han; Park, Kinam (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198-205
Bae, You Han (2009) Drug targeting and tumor heterogeneity. J Control Release 133:2-3

Showing the most recent 10 out of 16 publications